查看購物車
  • Simplified Chinese
  • English
  • Japanese
創傷護理管理(WCM)的世界市場規模，趨勢，分析:各產品類型，各地區，市場區隔預測(～2033年)
市場調查報告書
商品編碼
1366556

創傷護理管理(WCM)的世界市場規模，趨勢，分析:各產品類型，各地區，市場區隔預測(～2033年)

Wound Care Management (WCM) Market Size, Trends and Analysis by Product Type, Region and Segment Forecast to 2033
出版日期: | 出版商: GlobalData | 英文 614 Pages | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球傷口護理管理 (WCM) 市場規模預計將在 2023 年達到 300 億美元，在預測期內（2023-2033 年）複合年增長率為 3.8%。該市場主要由傷口護理管理技術進步、手術數量增加、人口老化和慢性病盛行率所推動。這使得企業能夠優化每個接觸點並改善整體客戶體驗。

本報告提供全球創傷護理管理(WCM)市場相關調查分析，提供主要的推動要素與課題，主要指標的預測，企業簡介等資訊。

目錄

第1章 摘要整理

第2章 調查範圍和市場區隔

  • 創傷護理管理(WCM):市場區隔和範圍
  • 創傷護理管理(WCM):市場定義

第3章 創傷護理管理(WCM) - 產業趨勢的分析

  • 創傷護理管理(WCM) - 推動市場要素
  • 創傷護理管理(WCM) - 阻礙市場要素
  • 創傷護理管理(WCM) - 法規形勢
  • 創傷護理管理(WCM) - 宏觀趨勢

第4章 創傷護理管理(WCM)的全球預測

  • 全球創傷護理管理(WCM)市場 - 收益概述
  • 全球創傷護理管理(WCM):詳細的市場規模的估計
  • 全球創傷護理管理(WCM)的商機:各產品類型
  • 全球WCM市場 - 各地區(2021年～2033年)

第5章 創傷護理管理(WCM)的地區預測

  • 創傷護理管理(WCM) - 地區概要與分析
  • 北美的創傷護理管理(WCM)市場 - 概要(2021年～2033年)
    • 北美的創傷護理管理(WCM)的商機:各產品類型(2021年～2033年)
    • 美國的創傷護理管理(WCM)市場 - 概要(2021年～2033年)
    • 加拿大的創傷護理管理(WCM)市場 - 概要(2021年～2033年)
    • 墨西哥的創傷護理管理(WCM)市場 - 概要(2021年～2033年)
  • 歐洲的創傷護理管理(WCM)市場 - 概要(2021年～2033年)
    • 歐洲的創傷護理管理(WCM)的商機:各產品類型(2021年～2033年)
    • 法國的創傷護理管理(WCM)市場 - 概要(2021年～2033年)
    • 德國的創傷護理管理(WCM)市場 - 概要(2021年～2033年)
    • 義大利的創傷護理管理(WCM)市場 - 概要(2021年～2033年)
    • 西班牙的創傷護理管理(WCM)市場 - 概要(2021年～2033年)
    • 荷蘭的創傷護理管理(WCM)市場 - 概要(2021年～2033年)
    • 瑞士的創傷護理管理(WCM)市場 - 概要(2021年～2033年)
    • 英國的創傷護理管理(WCM)市場 - 概要(2021年～2033年)
    • 其他的歐洲的創傷護理管理(WCM)市場 - 概要(2021年～2033年)

第6章 競爭情形

  • 創傷護理管理:競爭情形概要
  • 創傷護理管理:企業佔有率分析

第7章 企業簡介

  • 3M Co
  • AbbVie Inc
  • B. Braun Melsungen AG
  • Becton Dickinson and Co
  • Baxter International Inc
  • Cardinal Health
  • Coloplast Corp
  • Convatec Group Plc
  • BSN medical GmbH (Essity AB)
  • Integra LifeSciences Holdings Corp
  • Investor AB (Molnlycke Health Care AB)
  • Johnson & Johnson
  • Medline Industries LP
  • Medtronic Plc
  • Mimedx Group, Inc.
  • Paul Hartmann AG
  • Smith & Nephew Plc
  • Stryker Corp
  • Tactile Systems Technology Inc.
  • Teleflex Inc
  • Sechrist Industries Inc
  • Perry Baromedical Corporation
  • Haux-Life-Support GmbH

第8章 調查手法

第9章 關於GlobalData

簡介目錄
Product Code: GRCBBR00002ME

Abstract

The Wound Care Management (WCM) market will be valued at $30.0 billion in 2023 and is expected to grow at a CAGR of 3.8% over the forecast period (2023-2033). The WCM report provides an executive-level overview of the wounf care industry worldwide today, with detailed forecasts of key indicators up to 2033.

This market intelligence report offers a thorough, forward-looking analysis of the global Wound Care Management (WCM) market by product type, regional segments, and key opportunities in a concise format to help executives build proactive and profitable growth strategies.

Wound Care Management (WCM) market will be valued at $30.0 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 3.8% over the forecast period. The wound care management market comprises of dressings, equipment and other aids to prevent, treat wounds and also quicken or promote wound healing. The wound care management market covers advanced wound management, compression therapy, hyperbaric oxygen chambers, negative pressure wound therapy (NPWT), ostomy drainage bags, pressure relief devices, surgical sutures, tissue engineered - skin substitutes, traditional wound management, wound closure devices and wound debridement devices. The market is largely driven due to technological advancements in wound care management, increase in number of surgical procedures, ageing population, and increase in prevalence of chronic diseases. This helps businesses optimize each touchpoint and enhance the overall customer experience.

Scope

  • This report provides overview and service addressable market for global Wound Care Management (WCM) market
  • It identifies the key drivers and challenges impacting growth of the WCM market over the next 12 to 24 months.
  • It includes global market forecasts for the WCM market and analysis of latest M&A deals, regulatory trends, and reimbursement scenario.
  • It covers detailed segmentation by product type and regional segmentation.

Reasons to Buy

  • This market intelligence report offers a thorough, forward-looking analysis of the global Wound Care Management (WCM) market by product type, regional segments, and key opportunities in a concise format to help executives build proactive and profitable growth strategies.
  • Accompanying GlobalData's Forecast products, the report examines the drivers, challenges, trend analysis in the WCM market.
  • Detailed segmentation by product type traditional wound management, wound dressings, compression therapy, npwt (negative pressure wound therapy) devices, ostomy drainage bags, tissue sealants and adhesives, surgical sutures, tissue engineered skin substitutes, pressure relief devices, ligating clips, topical absorbable hemostats, oxygen therapy devices, wound contact layers, surgical adhesion barriers, and others (wound closure strips, superabsorbents, and wound debridement devices). Further, the report also highlights segmentation by region.
  • The report includes 100+ charts and tables providing in-depth analysis of the market size, forecast, and supporting factors which are tailor-made for an executive-level audience, with enhanced presentation quality.
  • The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from local market players, which enables executives to quickly get up to speed with the current and emerging trends in WCM markets.
  • The competitive section of the report helps in identifying the flagbearers, experimenters, contenders, and specialists based on their growth and innovation performance in the WCM industry which will help stakeholders analyze competition penetration.
  • The broad perspective of the report, coupled with comprehensive, actionable detail, will help WCM vendors and other companies succeed in the growing WCM market globally.

Table of Contents

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Research Scope and Segmentation

  • 2.1 Wound Care Management (WCM): Market Segmentation and Scope
  • 2.2 Wound Care Management (WCM): Market Definitions

Chapter 3 Wound Care Management (WCM) - Industry Trend Analysis

  • 3.1 Wound Care Management (WCM) - Market Drivers
  • 3.2 Wound Care Management (WCM) - Market Restraints
  • 3.3 Wound Care Management (WCM) - Regulatory Landscape
  • 3.4 Wound Care Management (WCM) - Macroeconomic Trends

Chapter 4 Wound Care Management (WCM) Global Outlook

  • 4.1 Global Wound Care Management (WCM) Market - Revenue Snapshot ($ Billion)
  • 4.2 Global Wound Care Management (WCM): Detailed Market Size Estimates
  • 4.3 Global Wound Care Management (WCM) Revenue Opportunity by Product Type
  • 4.4 Global WCM Market - By Region, 2021-2033 ($ Million)

Chapter 5 Wound Care Management (WCM) Regional Outlook

  • 5.1 Wound Care Management (WCM) - Regional Overview & Analysis
  • 5.2 North America Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Billion)
    • 5.2.1 North America Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.2.2 US Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.2.2.1 US Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.2.3 Canada Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.2.3.1 Canada Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.2.4 Mexico Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.2.4.1 Mexico Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
  • 5.3 Europe Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Billion)
    • 5.3.1 Europe Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.2 France Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.2.1 France Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.3 Germany Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.2.1 Germany Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.4 Italy Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.4.1 Italy Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.5 Spain Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.5.1 Spain Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.6 The Netherlands Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.6.1 The Netherlands Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.7 Switzerland Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.7.1 Switzerland Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.8 UK Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.8.1 UK Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)
    • 5.3.9 Rest of Europe Wound Care Management (WCM) Market - Overview, 2021-2033 ($ Million)
    • 5.3.9.1 Rest of Europe Wound Care Management (WCM) Revenue Opportunity by Product Type, 2021-2033 ($ Million)

Chapter 6 Competitive Landscape

  • 6.1 Wound Care Management: Competitive Landscape Overview
  • 6.2 Wound Care Management: Company Share Analysis

Chapter 7 Company Profiles

  • 7.1 3M Co
    • 7.1.1 3M Co: WCM Offerings
    • 7.1.2 3M Co: Financials
    • 7.1.3 3M Co: SWOT Analysis
    • 7.1.4 3M Co: Key Personnel
  • 7.2 AbbVie Inc
    • 7.2.1 AbbVie Inc: WCM Offerings
    • 7.2.2 AbbVie Inc: Financials
    • 7.2.3 AbbVie Inc: SWOT Analysis
    • 7.2.4 AbbVie Inc: Key Personnel
  • 7.3 B. Braun Melsungen AG
    • 7.3.1 B. Braun Melsungen AG: WCM Offerings
    • 7.3.2 B. Braun Melsungen AG: Financials
    • 7.3.3 B. Braun Melsungen AG: SWOT Analysis
    • 7.3.4 B. Braun Melsungen AG: Key Personnel
  • 7.4 Becton Dickinson and Co
    • 7.4.1 Becton Dickinson and Co: WCM Offerings
    • 7.4.2 Becton Dickinson and Co: Financials
    • 7.4.3 Becton Dickinson and Co: SWOT Analysis
    • 7.4.4 Becton Dickinson and Co: Key Personnel
  • 7.5 Baxter International Inc: Overview
    • 7.5.1 Becton Dickinson and Co: WCM Offerings
    • 7.5.2 Becton Dickinson and Co: Financials
    • 7.5.3 Becton Dickinson and Co: SWOT Analysis
    • 7.5.4 Becton Dickinson and Co: Key Personnel
  • 7.6 Cardinal Health: Overview
    • 7.6.1 Cardinal Health: WCM Offerings
    • 7.6.2 Cardinal Health: Financials
    • 7.6.3 Cardinal Health: SWOT Analysis
    • 7.6.4 Cardinal Health: Key Personnel
  • 7.7 Coloplast Corp: Overview
    • 7.7.1 Coloplast Corp: WCM Offerings
    • 7.7.2 Coloplast Corp: Key Personnel
  • 7.8 Convatec Group Plc: Overview
    • 7.8.1 Convatec Group Plc: WCM Offerings
    • 7.8.2 Convatec Group Plc: Financials
    • 7.8.3 Convatec Group Plc: SWOT Analysis
    • 7.8.4 Convatec Group Plc: Key Personnel
  • 7.9 BSN medical GmbH (Essity AB): Overview
    • 7.9.1 BSN medical GmbH (Essity AB): WCM Offerings
    • 7.9.2 BSN medical GmbH (Essity AB): SWOT Analysis
    • 7.9.3 BSN medical GmbH (Essity AB): Key Personnel
  • 7.10 Integra LifeSciences Holdings Corp: Overview
    • 7.10.1 Integra LifeSciences Holdings Corp: WCM Offerings
    • 7.10.2 Integra LifeSciences Holdings Corp: Financials
    • 7.10.3 Integra LifeSciences Holdings Corp: SWOT Analysis
    • 7.10.4 Integra LifeSciences Holdings Corp: Key Personnel
  • 7.11 Investor AB (Molnlycke Health Care AB): Overview
    • 7.11.1 Investor AB (Molnlycke Health Care AB): WCM Offerings
    • 7.11.2 Investor AB (Molnlycke Health Care AB): Financials
    • 7.11.3 Investor AB (Molnlycke Health Care AB): SWOT Analysis
    • 7.11.4 Investor AB (Molnlycke Health Care AB): Key Personnel
  • 7.12 Johnson & Johnson: Overview
    • 7.12.1 Johnson & Johnson: WCM Offerings
    • 7.12.2 Johnson & Johnson: Financials
    • 7.12.3 Johnson & Johnson: SWOT Analysis
    • 7.12.4 Johnson & Johnson: Key Personnel
  • 7.13 Medline Industries LP: Overview
    • 7.13.1 Medline Industries LP: WCM Offerings
  • p7.13.2 Medline Industries LP: SWOT Analysis
    • 7.13.3 Medline Industries LP: Key Personnel
  • 7.14 Medtronic Plc: Overview
    • 7.14.1 Medtronic Plc: WCM Offerings
    • 7.14.2 Medtronic Plc: Financials
    • 7.14.3 Medtronic Plc: SWOT Analysis
    • 7.14.4 Medtronic Plc: Key Personnel
  • 7.15 Mimedx Group, Inc.: Overview
    • 7.15.1 Mimedx Group, Inc: WCM Offerings
    • 7.15.2 Mimedx Group, Inc: Financials
    • 7.15.3 Mimedx Group, Inc: Key Personnel
  • 7.16 Paul Hartmann AG: Overview
    • 7.16.1 Paul Hartmann AG: WCM Offerings
    • 7.16.2 Paul Hartmann AG: Financials
    • 7.16.3 Paul Hartmann AG: SWOT Analysis
    • 7.16.4 Paul Hartmann AG: Key Personnel
  • 7.17 Smith & Nephew Plc: Overview
    • 7.17.1 Smith & Nephew Plc: WCM Offerings
    • 7.17.2 Smith & Nephew Plc: Financials
    • 7.17.3 Smith & Nephew Plc: SWOT Analysis
    • 7.17.4 Smith & Nephew Plc: Key Personnel
  • 7.18 Stryker Corp: Overview
    • 7.18.1 Stryker Corp: WCM Offerings
    • 7.18.2 Stryker Corp: Financials
    • 7.18.3 Stryker Corp: SWOT Analysis
    • 7.18.4 Stryker Corp: Key Personnel
  • 7.19 Tactile Systems Technology Inc.: Overview
    • 7.19.1 Tactile Systems Technology Inc.: WCM Offerings
    • 7.19.2 Tactile Systems Technology Inc.: Financials
    • 7.19.3 Tactile Systems Technology Inc.: SWOT Analysis
    • 7.19.4 Tactile Systems Technology Inc.: Key Personnel
  • 7.20 Teleflex Inc: Overview
    • 7.20.1 Teleflex Inc: WCM Offerings
    • 7.20.2 Teleflex Inc: Financials
    • 7.20.3 Teleflex Inc: SWOT Analysis
    • 7.20.4 Teleflex Inc: Key Personnel
  • 7.21 Sechrist Industries Inc: Overview
    • 7.21.1 Sechrist Industries Inc: WCM Offerings
    • 7.21.2 Sechrist Industries Inc: Key Personnel
  • 7.22 Perry Baromedical Corporation: Overview
    • 7.22.1 Perry Baromedical Corporation: WCM Offerings
    • 7.22.2 Perry Baromedical Corporation: Key Personnel
  • 7.23 Haux-Life-Support GmbH: Overview
    • 7.23.1 Haux-Life-Support GmbH: WCM Offerings

Chapter 10 Research Methodology

Chapter 11 About GlobalData